GSK (NYSE: GSK) president credited notional ADS in executive savings plan

Rhea-AI Filing Summary

GSK plc reported an insider transaction involving President Maya Martinez-Davis. She acquired notional American Depositary Shares (ADS) through her GSK Executive Supplemental Savings Plan account. The plan credited 9.293 ADS at a price of $51.3800 per ADS on May 22, 2026, with the transaction executed on the New York Stock Exchange.

Key Figures

ADS volume acquired: 9.293 ADS ADS price: $51.3800 per ADS Transaction date: May 22, 2026

3 metrics

ADS volume acquired 9.293 ADS Notional ADS credited to Executive Supplemental Savings Plan

ADS price $51.3800 per ADS Price used for the notional ADS acquisition on May 22, 2026

Transaction date May 22, 2026 Date of notional ADS acquisition on NYSE (XNYS)

Key Terms

American Depositary Shares, Executive Supplemental Savings Plan, PDMR, LEI

4 terms

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS') ISIN: US37733W2044"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Executive Supplemental Savings Plan financial

"Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account"

PDMR regulatory

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

LEI regulatory

"b) | LEI | 5493000HZTVUYLO1D793"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

​

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Maya Martinez-Davis
b)	Position/status	President, US
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$51.3800	9.293
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2026-05-22
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: May 27, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc

FAQ

What insider transaction did GSK (GSK) report in this Form 6-K?

GSK reported that President Maya Martinez-Davis acquired notional American Depositary Shares through her GSK Executive Supplemental Savings Plan. The transaction involved 9.293 ADS credited at $51.3800 per ADS, reflecting a routine compensation-related acquisition rather than an open-market trade.

Who is the insider involved in the latest GSK (GSK) transaction?

The insider is Maya Martinez-Davis, a President at GSK. She received notional ADS within her GSK Executive Supplemental Savings Plan account, rather than buying shares directly on the market, as part of her executive compensation arrangements disclosed in the report.

How many GSK (GSK) ADS were acquired and at what price?

The plan credited 9.293 GSK American Depositary Shares at a price of $51.3800 per ADS. This was a single aggregated transaction recorded within the GSK Executive Supplemental Savings Plan on the New York Stock Exchange on May 22, 2026.

What type of instrument was involved in the GSK (GSK) insider transaction?

The instrument was GSK American Depositary Shares (ADS) with ISIN US37733W2044. These ADS represent an interest in GSK’s equity and were credited notionally to Maya Martinez-Davis’s Executive Supplemental Savings Plan account, rather than being directly purchased in a standard brokerage account.

Where and when was the GSK (GSK) insider transaction executed?

The transaction took place on the New York Stock Exchange (XNYS) on May 22, 2026. GSK’s filing reports this as a single transaction in which notional ADS were acquired within an executive supplemental savings plan, rather than multiple trades spread across different venues.

Is the GSK (GSK) insider transaction part of an executive compensation plan?

Yes. The filing states it is an acquisition of notional ADS within Ms Martinez-Davis’s GSK Executive Supplemental Savings Plan account. This indicates the transaction is compensation-related, aligning with structured benefit arrangements rather than discretionary open-market share purchases.